Irinotecan binds to the internal cavity of beta-lactoglobulin: A multi-spectroscopic and computational investigation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 139, Issue , 2017, Pages 109-115

  Bijari, N ^a   Ghobadi, S ^a   Derakhshandeh, K ^b  

^a RAZI UNIVERSITY   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta Lactoglobulin; Colon cancer; Fluorescence quenching; Irinotecan; Non radiative energy transfer; Partial compactness

Indexed keywords

BETA LACTOGLOBULIN; IRINOTECAN; CAMPTOTHECIN; LACTOGLOBULIN;

ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENERGY TRANSFER; FLUORESCENCE ANALYSIS; FLUOROMETRY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOLECULAR DOCKING; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SPECTROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ANALOGS AND DERIVATIVES; ANIMAL; BINDING SITE; BOVINE; CHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; BINDING SITES; CAMPTOTHECIN; CATTLE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LACTOGLOBULINS; MOLECULAR DOCKING SIMULATION; PROTEIN STRUCTURE, SECONDARY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 85014460685     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2017.02.050     Document Type: Article

References (29)

1. [1] Le Maux, S., Bouhallab, S., Giblin, L., Brodkorb, A., Croguennec, T., Bovine β-lactoglobulin/fatty acid complexes: binding, structural, and biological properties. Dairy Sci. Technol. 94 (2014), 409–426.
2. [2] Flower, D.R., The lipocalin protein family: a role in cell regulation. FEBS Lett. 354 (1994), 7–11.
3. [3] Dufour, E., Haertlé, T., Binding affinities of beta-ionone and related flavor compounds to beta-lactoglobulin: effects of chemical modifications. J. Agric. Food Chem. 38 (1990), 1691–1695.
4. [4] Gunasekaran, S., Ko, S., Xiao, L., Use of whey proteins for encapsulation and controlled delivery applications. J. Food Eng. 83 (2007), 31–40.
5. [5] Chourasia, M.K., Jain, S.K., Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6 (2003), 33–66.
6. [6] Rytkönen, J., Effect of Heat Denaturation of Bovine Milk Beta-Lactoglobulin on Its Epithelial Transport and Allergenicity. 2006, Oulu University Press, Oulu.
7. [7] Maity, S., Pal, S., Sardar, S., Sepay, N., Parvej, H., Chakraborty, J., Halder, U.C., Multispectroscopic analysis and molecular modeling to investigate the binding of beta lactoglobulin with curcumin derivatives. RSC Adv. 6 (2016), 112175–112183.
8. [8] Ghalandari, B., Divsalar, A., Saboury, A.A., Parivar, K., The new insight into oral drug delivery system based on metal drugs in colon cancer therapy through b-lactoglobulin/oxali-palladium nanocapsules. J. Photochem. Photobiol. B 140 (2014), 255–265.
9. [9] Fuchs, C., Mitchell, E.P., Hoff, P.M., Irinotecan in the treatment of colorectal cancer. Cancer Treat. Rev. 32 (2006), 491–503.
10. [10] Calvo, E., Cortés, J., Rodríguez, J., Fernández-Hidalgo, O., Rebollo, J., Martín-Algarra, S., García-Foncillas, J., Martínez-Monge, R., de Irala, J., Brugarolas, A., Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. Clin. Colorectal Cancer 2 (2002), 104–110.
11. [11] Ghalandari, B., Divsalar, A., Saboury, A.A., Haertlé, T., Parivar, K., Bazl, R., Eslami-Moghadam, M., Amanlou, M., Spectroscopic and theoretical investigation of oxali–palladium interactions with β-lactoglobulin. Spectrochim. Acta Part A 118 (2014), 1038–1046.
12. [12] Yeggoni, D.P., Kuehne, C., Rachamallu, A., Subramanyam, R., Elucidating the binding interaction of andrographolide with the plasma proteins: biophysical and computational approach. RSC Adv. 7 (2017), 5002–5012.
13. [13] Bijari, N., Ghobadi, S., Mahdiuni, H., Khodarahmi, R., Ghadami, S.A., Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II. Int. J. Biol. Macromol. 80 (2015), 189–199.
14. [14] Shen, G.F., Liu, T.T., Wang, Q., Jiang, M., Shi, J.H., Spectroscopic and molecular docking studies of binding interaction of gefitinib, lapatinib and sunitinib with bovine serum albumin (BSA). J. Photochem. Photobiol. B 153 (2015), 380–390.
15. [15] Chaturvedi, S.K., Ahmad, E., Khan, J.M., Alam, P., Ishtikhar, M., Khan, R.H., Elucidating the interaction of limonene with bovine serum albumin: amulti-technique approach. Mol. Biosyst. 11 (2015), 307–316.
16. [16] Sahoo, H., Förster resonance energy transfer–A spectroscopic nanoruler: principle and applications. J. Photochem. Photobiol. C 12 (2011), 20–30.
17. [17] Chen, T., Cao, H., Zhu, S., Lu, Y., Shang, Y., Wang, M., Tang, Y., Zhu, L., Investigation of the binding of Salvianolic acid B to human serum albumin and the effect of metal ions on the binding. Spectrochim. Acta A 81 (2011), 645–652.
18. [18] Trott, O., Olson, A.J., AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31 (2010), 455–461.
19. [19] Ranjbar, S., Ghobadi, S., Khodarahmi, R., Nemati, H., Spectroscopic characterization of furosemide binding to human carbonic anhydrase II. Int. J. Biol. Macromol. 50 (2012), 910–917.
20. [20] Evale, B.G., Hanagodimath, S.M., Static and dynamic quenching of biologically active coumarin derivative by aniline in benzene-acetonitrile mixtures. J. Lumin. 130 (2010), 1330–1337.
21. [21] Sun, Y., Wei, S., Yin, C., Liu, L., Hu, C., Zhao, Y., Ye, Y., Hu, X., Fan, J., Synthesis and spectroscopic characterization of 4-butoxyethoxy-N-octadecyl-1,8-naphthalimide as a new fluorescent probe for the determination of proteins. Bioorg. Med. Chem. Lett. 21 (2011), 3798–3804.
22. [22] Airinei, A., Tigoianu, R.I., Rusu, E., Dorohoi, D.O., Fluorescence quenching of anthracene by nitroaromatic compounds. Digest J. Nanomater. Biostruct. 6 (2011), 1265–1272.
23. +3. Protein J. 25 (2006), 157–165.
24. [24] Wu, X., Liu, J., Wang, Q., Xue, W., Yao, X., Zhang, Y., Jin, J., Spectroscopic and molecular modeling evidence of clozapine binding to human serum albumin at subdomain IIA. Spectrochim. Acta Part A 79 (2011), 1202–1209.
25. [25] Jiang, C.Q., Wang, T., Study of the interactions between tetracycline analogues and lysozyme. Bioorg. Med. Chem. 12 (2004), 2043–2047.
26. [26] Liu, X., Ling, Z., Zhou, X., Ahmad, F., Zhou, Y., Comprehensive spectroscopic probing the interaction and conformation impairment of bovine serum albumin (BSA) by herbicide butachlor. J. Photochem. Photobiol. B 162 (2016), 332–341.
27. [27] Gao, W., Li, N., Chen, Y., Xu, Y., Lin, Y., Yin, Y., Hu, Z., Study of interaction between syringin and human serum albumin by multi-spectroscopic method and atomic force microscopy. J. Mol. Struct. 983 (2010), 133–140.
28. [28] Naik, P.N., Nandibewoor, S.T., Chimatadar, S.A., Non-covalent binding analysis of sulfamethoxazole to human serum albumin: fluorescence spectroscopy, UV–vis, FT-IR, voltammetric and molecular modeling. J. Pharm. Anal. 5 (2015), 143–152.
29. [29] Jiang, M., Xie, M.-X., Zheng, D., Liu, Y., Li, X.-Y., Chen, X., Spectroscopic studies on the interaction of cinnamic acid and its hydroxyl derivatives with human serum albumin. J. Mol. Struct. 692 (2004), 71–80.